Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine

Leukemia. 2010 Jan;24(1):236-7. doi: 10.1038/leu.2009.204. Epub 2009 Sep 24.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Middle Aged
  • Neoplasm, Residual
  • Nuclear Proteins / analysis*
  • Nuclear Proteins / genetics
  • Nucleophosmin
  • Proto-Oncogene Proteins c-abl / analysis
  • Recurrence

Substances

  • Antimetabolites, Antineoplastic
  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin
  • Proto-Oncogene Proteins c-abl
  • Azacitidine